Pinnow Cole 4
4 · Cogent Biosciences, Inc. · Filed May 29, 2024
Insider Transaction Report
Form 4
Pinnow Cole
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-05-25+525,000→ 525,000 totalExercise: $8.22Exp: 2034-05-25→ Common Stock (525,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest 25% on the first anniversary of May 25, 2024, with the remainder vesting in equal monthly installments through May 25, 2028, subject to the Reporting Person's continued service to the Issuer.